| 000 | 01064 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250513075104.0 | ||
| 264 | 0 | _c19931101 | |
| 008 | 199311s 0 0 eng d | ||
| 022 | _a0167-5699 | ||
| 024 | 7 |
_a10.1016/0167-5699(93)90051-L _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPardoll, D M | |
| 245 | 0 | 0 |
_aCancer vaccines. _h[electronic resource] |
| 260 |
_bImmunology today _cJun 1993 |
||
| 300 |
_a310-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAdjuvants, Immunologic _xtherapeutic use |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntigens, Neoplasm _ximmunology |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aCytokines _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunotherapy, Active |
| 650 | 0 | 4 |
_aMajor Histocompatibility Complex _xgenetics |
| 650 | 0 | 4 |
_aNeoplasms _ximmunology |
| 650 | 0 | 4 |
_aVaccines, Synthetic _xtherapeutic use |
| 773 | 0 |
_tImmunology today _gvol. 14 _gno. 6 _gp. 310-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0167-5699(93)90051-L _zAvailable from publisher's website |
| 999 |
_c8397045 _d8397045 |
||